Comparison 9: NaSSAs vs placebo
Dropouts due to adverse events · adults (aged 18‐85)
Comparison 4: NaSSAs showed no clear difference in treatment tolerability, as measured by Dropouts due to adverse… compared with placebo (low certainty).
1 finding from 1 review
- RR 0.87 [0.68, 1.11]1 study · 36 participantsLow